Synthesis and evaluation of polymeric micelle containing piperacillin/tazobactam for enhanced antibacterial activity
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 26 (1) , 1292-1299
Abstract
Infections caused by multidrug-resistant bacteria such as P. aeruginosa are important therapeutic complications. Piperacillin/Tazobactam is considered a safe antimicrobial agent. But we should not ignore the prevalence of resistant strains to this drug. In this work, a new polymeric micelle composed of Piperacillin/Tazobactam-loaded Poly (ethylene glycol) methyl ether-block-poly (lactide-co-glycolide) (PLGA-PEG) was developed to improve the antimicrobial performance of P/T. The SEM and TEM studies of PLGA-PEG micelle showed, semi-spherical morphology with a mean diameter of below 30 nm. Zeta potential results indicated that the surface charge of PLGA-PEG micelle was −2.98 mV, while after encapsulation of P/T, the surface charge decreases to −4.13 mV. Clinical strains of P. aeruginosa were isolated and their resistance pattern against different antibiotics was evaluated. The MIC of free and P/T -Loaded PLGA-PEG micelles was determined. Also, the effect of free or P/T micelle against minimal biofilm eradication concentration and motility inhibition was evaluated. The bacterial isolates were resistant to most common antibiotics. The MIC of the free drug form and micelle form ranged from 4 to 512 µg/ml and 2 to 256 µg/ml, respectively. Generally, micelle showed more effective antibiofilm activities, inhibition of bacterial motility and reducing the MIC than that free drug form.Keywords
This publication has 31 references indexed in Scilit:
- Surface-Enhanced Raman Scattering-Active Nanostructures and Strategies for BioassaysNanomedicine, 2011
- Reducing infections through nanotechnology and nanoparticlesInternational Journal of Nanomedicine, 2011
- Development of azithromycin–PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhiColloids and Surfaces B: Biointerfaces, 2010
- Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Detection of metallo-β-lactamase–producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, IranDiagnostic Microbiology and Infectious Disease, 2008
- Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococciAPMIS, 2007
- Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing StrategyClinical Infectious Diseases, 2007
- Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosaJournal of Medical Microbiology, 2004
- Mechanisms of bacterial pathogenicityPostgraduate Medical Journal, 2002
- The role of motility as a virulence factor in bacteriaInternational Journal of Medical Microbiology, 2002